CHIANG YAWEN L 4
4 · CORAUTUS GENETICS INC · Filed Oct 15, 2003
Insider Transaction Report
Form 4
CHIANG YAWEN L
VP-Mfg, Chf Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2003-10-13+50,000→ 50,000 totalExercise: $4.78From: 2003-10-13Exp: 2013-10-13→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]Stock options vest according to the following schedule: (i) 15,000 upon completion of all preclinical studies for catheter used in Issuer's Phase II(b) clinical trial; (ii) 10,000 upon the Issuer's execution of a contract for Phase III trial manufacturer; (iii) 10,000 upon completion of VEGF-2 assay development plan for Phase III trial material; (iv) 15,000 upon completion of manufacturing of Phase III trial plasmid; and (v) all remaining unvested options on October 13, 2005.